New therapy for rare leukemias

Researchers from the University of Helsinki, HUS Comprehensive Cancer Center and the University of Copenhagen have identified a potential new targeted therapy option for treating two rare subtypes (erythroid or megakaryoblastic)of acute myeloid leukemia using BCL-XL protein inhibitors. This could…




